SNES.US SenesTech Inc

Basic Materials Pharmaceuticals USA Stocks
0.8098 USD
Close of Nov 17, 2026
0.5500 3.03
Market cap
USD 5.53M
P/E
-
P/B
1.02x
ROE
-169.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is SNES.US undervalued?

Graham number

The Graham number of SenesTech Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

SenesTech Inc fundamental analysis

No fundamental analysis for SenesTech Inc yet.

SenesTech Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About SenesTech Inc

SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption. It also develops Evo…

Full company profile